The Nifty extended its losing streak with a sixth consecutive decline, slipping below the 25,000 support level amid broad-based selling, especially in pharma and IT stocks. Analysts warn of further downside if 24,500 breaks, though a recovery remains possible. Stock recommendations include Ashok Leyland, Dr Agarwal’s Health Care, Dixon, and Anant Raj.
New investor additions in markets declined by 11.6% in November (MoM): NSE Report
The pace of new investor additions in the equity markets slowed in November, with growth declining 11.6 per cent month-on-month, as only 13.2 lakh new